chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fainted; This is a spontaneous report from a contactable consumer (patient) reported that a 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 12Mar2021 11:30 as a single dose (at the age of 60-years-old) for covid-19 immunisation. The patient medical history was reported as none. The patient was not pregnant at the time of vaccination. Concomitant medications included glipizide and lisinopril both were taken for an unspecified indication, start and stop date were not reported. On 13Mar2021 14:30, the patient fainted and was rushed to the hospital and admitted with outcome of recovered on Mar2021. The reported event resulted in emergency room/department or urgent care, and hospitalization for 1 day on an unspecified date. The patient received treatment for the reported event as Catscan (as reported). The patient underwent lab tests and procedures which included sars-cov-2 test (nasal swab): negative on 13Mar2021.   Information on Lot/batch number has been requested.
mom reported stiffening of arms, panic look on face 1 hr p/vax, lasting 1 second; mom thinks pt had same react @ age 2 months p/vax;
Left wrist pain began one day after vaccine placed. Has persisted, though is improving gradually. Pain occurs with wrist movement only. No swelling or redness. No hand or finger involvement. No treatment.
CHILLS; fever (100.7° F); A spontaneous report was received from a consumer concerning a 72-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fever (100.7° F) and chills.  The patient's medical history, as provided by the reporter, included that he is on Diabetes treatment. He was diagnosed with COVID-19 on 06 Dec 2021. No Concomitant medications were provided.  On 06 Jan 2021 prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) in the left arm for prophylaxis of COVID-19 infection.   On the morning of 07 Jan 2021, the patient experienced fever (100.7° F) and chills. Treatment for the events included paracetamol.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events,fever (100.7° F) and chills were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient seen in emergency department with new onset lower abdominal pain, bright red blood in stool, Nausea and vomiting. Noted drops of blood in toilet.
lost partial vision in my right eye which has been determined to be a AION; blood pressure elevated; weak; dizzy; nauseated; fever; headache; This is a spontaneous report from a contactable consumer (patient). This 71- year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Lot number: EN6208), via an unspecified route of administration, on 11Mar2021 at 16:00 (at the age of 71-years-old) as a single dose for COVID-19 vaccination, in left arm. The facility where COVID-19 vaccine was administered was Public Health Clinic facility. Historical vaccine included: bnt162b2 (COMIRNATY, Solution for injection, Lot number EN6200) dose 1 on 18Feb2021 04:00 PM, for covid-19 immunization, left arm. No known allergies. The medical history included: Blood pressure abnormal. Concomitant medications included: Prozac, Inderal, Atorvastatin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Mar2021 09:00 am, Day after 2nd injection, she felt weak, dizzy, nauseated, fever, blood pressure elevated and had an extremely severe headache. That evening I lost partial vision in my right eye, which has been determined to be AION. Vision has not returned at one month out. Event resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Disability or permanent damage. Treatment included: Blood pressure monitoring and return 13Apr2021. The clinical outcome of the events was not recovered. The patient was not tested for COVID-19 after the vaccination.  No follow-up attempts are possible. No further information is expected.
2 minutes after receiving her COVID vaccine, per Dad, patient screamed, said her arm really hurt, fell back onto the exam table where she had been sitting with eyes rolled upwards and peed herself. MA and I were in the room within 30 seconds. Patient was unresponsive and staring straight up at the ceiling. SpO2 99%, HR 110s. After 10 seconds of tactile stimulation and talking to her, patient became responsive. Was very slow to respond but said her name. Was unable to state her age, where she was, or who her Dad was. BP 90s/60s. POC glucose 80. After 5 minutes, was able to respond more with the names of her siblings and who she lived with at home but still not back to baseline.   Sent to ED, labs done and pediatric neurology consulted. Thought to be most likely vasovagal syncope. Was back to baseline.
Information has been received from a physician concerning a 7 yr old white male with no medical history who on 08Oct98 was vaccinated with the first dose of varicella virus vaccine live. Concomitant vaccinations on that same day included the second dose of hep B virus vaccine rHBsAg (yeast). There was no illness at the time of vaccination. The physician reported that on the evening of 20Apr05, the pt developed mild chicken pox. Medical attention was not sought and the pt subsequently recovered from the chickenpox. Additional information is not expected.
Febrile seizure with postictal phase. 10/6/13 seen at ER.
As soon as shot was given warm sensation throughout body and metal taste in mouth. Felt dizzy for a minute as well
pt recvd vax & 7 hrs later exp stomach cramps, nausea, weakness, & h/a which lasted 24 hrs;
Patient received a vaccine past the 30 day storage on the refrigerator; Dose administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 immunisation.     Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC), ASPIRIN [ACETYLSALICYLIC ACID], FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR), LORATADINE, AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), ACYCLOVIR [ACICLOVIR] and SALBUTAMOL SULFATE (PROAIR HFA) for an unknown indication.    On 01-Apr-2022 at 9:18 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2022 at 9:18 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   COVID 19 test:: Negative within last month.  No Concomitant Products were reported. Date the vial was initially stored in the refrigerator: 25 Feb 2022. Expiration date of vaccine: 25 Mar 2022. Vial didn't undergo any temperature excursions. Patient not experienced any side effects yet. No Treatment information was reported.
Two days after shot, HA, Nausea, Fever, strong muscle/joint pain & burning.  Third day unable to go to work due to symptoms. Fourth  day went to work but came home feeling very sick with  SOB (pretty bad) chills or shaking, HA continued, One week after, still unable to go work due to symptoms.
This spontaneous report as received from a pharmacist via company representative refers to a male patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not specified by the reporter. On approximately 24-MAR-2015 (reported as two weeks ago), the patient was vaccinated by unspecified pharmacist with ZOSTAVAX (lot#/batch#, dose and route of administration, indication were unspecified). The patient developed shingles after getting ZOSTAVAX (on an unspecified date in 2015). It was not reported if the patient sought medical attention. The outcome of shingles was not reported. Action taken with ZOSTAVAX was reported as not applicable. The relatedness between the event and ZOSTAVAX was not reported. Additional information has been requested.
Approximately 8 hours after administration of second vaccine, patient began to feel chills; Approximately 8 hours after administration of second vaccine, patient began headache; Approximately 8 hours after administration of second vaccine, patient began nausea; This is a spontaneous report from a non-contactable consumer. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via intramuscular route of administration in the left arm on an unknown date in May2021 as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included vitamins (unspecified) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via intramuscular route of administration in the left arm on an unknown date in Apr2021 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in May2021, approximately 8 hours after administration of second vaccine, the patient began to feel chills, headache and nausea that lasted approximately 10 hours. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events feel chills, headache and nausea were recovered on an unknown date in May2021 (lasted approximately 10 hours).  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 85-year-old patient of unknown gender. No information regarding the patient's medical history and concomitant medications was reported. On or around 28-MAY-2013, at the age of 78 years, the patient was vaccinated by a pharmacist with ZOSTAVAX injection (route of administration, dose, vaccination site, lot # and expiry date were not reported) for long-term prevention of shingles and zoster-related conditions. On an unknown date, the patient experienced herpes zoster and herpes zoster neuropathy. On an unspecified date, the patient was treated by a physician for herpes zoster and herpes zoster neuropathy. The outcome of the events herpes zoster and herpes zoster neuropathy was not reported. The reporter considered the events to be related to ZOSTAVAX. Upon internal review, the event of herpes zoster neuropathy was determined to be medically significant. Additional information has been requested.
Immune system failure. Systemic reaction; Extreme fatigue and exhaustion, reddish grey skin, severe coughing, headache, chills, fever, red bloodshot and teary eyes, rapid heartbeat, dizziness, malaise, lassitude, nervousness, off balance feeling, yellow thick mucus poured from both nostrils, fingernails turned blue, nausea, and really sick for 2 years after the inoculations, lung damage, suppressed breathing, sleep apnea, sharp headaches, rheumatoid arthritis, joint pain, chest pain, kidney pain, gurgling sensation up the back of the neck to the base of the brain, mucus over production, smell reduced and can smell a strong glue smell and/or something nasty, stomach problems, overeating disorder, weight loss, chemical sensitivities, heat sensitivities, cannot do anything to over exert my body or I'll feel sick and extremely nauseated, time seemed to stop then slowed down, etc. I received the first anthrax vaccination series only but was forced to have to exit military duty due to illness. I almost died at least 20-50 times from sleep apnea alone.
Information has been received from a registered nurse concerning a 6 year old white male with no allergies or medical conditions whon 03FEB1998 was vaccinated in the left arm with a 0.5cc first dose of varicella virus vaccine live. There was no concomitant medication. There was no illness at the time of vaccination. On 21APR2003 the patient was seen for a rash around the genital area for one week (date of onset 14APR2003).  The reporter indicated that it looked more like blisters as the rash continued. It was noted that the patient was exposed to shingles the weekend before the outbreak. The patient was diagnosed with chickenpox and instructed to try oral dephenhydramine hydrochloride (BENADRYL) and acetaminophen (TYLENOL) and topical calamine lotion. No prescription drug treatment was required. The patient was "discharged and expected to have a fulll recovery." It was also noted that the patient recovered. There were no diagnostic tests or laboratory results. Additional info. not expected.
she has arthritis; joint pains; she can't stand, straighten her legs and cannot walk; she can't stand, straighten her legs and cannot walk; she can't stand, straighten her legs and cannot walk; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified gender received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on 24Mar2021, as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated she got her first dose of the Pfizer Covid 19 vaccine this 24Mar2021 and 2 1/2 days after, on an unspecified date in Mar2021, she experienced joint pains that she couldn't stand, straighten her legs and cannot walk. She had arthritis and asked was this was normal and how long it will last. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number can-not be obtained.
A swollen lymph node on right ear - hard painful knot - felt like a bruise - it kept swelling after a few days. I went to the doctor - I saw a Dr - as mine was on vacation. They gave me amoxicillin and through taking that it went away. It's completely gone away. It doesn't hurt to poke at it anymore.
she presented swelling in her ovaries and waist; swelling in her ovaries; she feels that "she is dying"; severe pain; the presence of "a ball" in her right hand; internal pressure in her left eye; This is a spontaneous report from a contactable consumer (patient) or other non HCP. A 61-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 06May2021 13:45 (Batch/Lot Number: EW010050) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history was not reported. There were no concomitant medications. On 2021, she feels that "she is dying," she presented swelling in her ovaries and waist, severe pain, the presence of "a ball" in her right hand, internal pressure in her left eye, swelling in her ovaries. It was informed that it was the Pfizer vaccine but she is not sure since she was only given "one little bottle" and another acquaintance of hers was given "two little bottles") in (withheld) on 06May2021, at 1:45 pm. Three days later she presented swelling in her ovaries and waist (similar to "as if she had a child") she also has pain and feels "a ball down there", severe pain in the areas already mentioned along with pain in her right hand, the presence of "a ball" in her right hand and internal pressure in her left eye. Due to the previously mentioned she had to go to the emergency room where after they did some studies on her she ended up not being treated. The patient has been taking naproxen for pain but her symptoms have remained for two months. An (name) of hers has had the same symptoms but she also had bleeding after receiving "two little bottles" of the vaccine. (name) should have received her second dose in July. She is in so much pain that she cannot travel to her place of work or to receive medical attention in another state, she mentioned that she feels that "she is dying". Therapeutic measures were taken as a result of severe pain (pain). The outcome of the events was unknown.   Follow-up attempts are completed. No further information is expected.
pt recvd vax;approx 1 1/2 hrs later,exp n,welts on face & neck;took dph & felt fine;next day sx worsened next day;in eve exp n,welts reappeared accompanied by itching;resolved & reoccurred next 2 eve;resolved w/ dph;
Symptomatic Covid infection confirmed by home antigen test ~4 months after booster.; Symptomatic Covid infection confirmed by home antigen test ~4 months after booster.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Sep2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), in Sep2022 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 19Jan2023, outcome "not recovered" and all described as "Symptomatic Covid infection confirmed by home antigen test ~4 months after booster.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (19Jan2023) Positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of drug ineffective, covid-19.  Clinical course: Prior vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Refer to continuation page. Within hours after my vaccination I began feeling slightly detached from what was going on around me, more like I was observing life rather than participating- - although I was active. This feeling continued and was more noticeable the second day before starting to recede. Right after that I began to discover that I had developed both a lack of recall (names, words) and lack of concentration. I would walk across the kitchen, reach a cupboard and could not remember what I went there to get. Or I would unthinkingly open the wrong cupboard or drawer. Also, I would walk off in the middle of doing something and forget about it until I passed by again and saw my unfinished project.  I began making an effort to remind myself of the names of flowers, trees, etc. in our yard. I looked up names of relatives in our family tree (my husband is the youngest of 11 children). Most of that re-learning has stuck with me, but sometimes not until after repeated times of reminding myself. Some problems have toned down but are still with me. Others still happen repeatedly such as misplacing my cell phone. Occasionally I forget to feed our feral outdoors cat until reminded, or I forget a load of dry clothes in the dryer for a day or two. While I don't require entering a senior eldercare facility, these side effects of the Shingrix vaccine have been a real nuisance.
This is a spontaneous report from a contactable consumer (patient). A 52-year-old male patient received his second dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EL3248; expiration date: unknown), via an unspecified route of administration right arm on 04Feb2021 07:45 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has no allergies to medications, food, or other products. The patient received his first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EL3248; expiration date: unknown) at the vaccination age of 52-year-old via an unspecified route of administration left arm on 14Jan2021 08:45 AM at a single dose for covid-19 immunization. On 04Feb2021 04:45 PM, the patient reported that he believed he experienced an ocular migraine in his left eye approximately 9 hours after getting the second shot. He took 2 acetaminophen 500 mg tablets and the symptoms cleared up in 20-30 minutes. He has never experienced this sort of sensation before so he figures it could possibly be related. He woke up with a mild headache at the start of this second day (05Feb2021), as well. The events were non-serious. The patient has not been tested for COVID-19 since the vaccination. The outcome of the event ophthalmic migraine was recovered on 04Feb2021 while headache was recovered on Feb2021.
Information has been received from a physician concerning a patient who on 16-OCT-2007 received a first subcutaneous dose in the left deltoid of zoster vaccine live (Oka/Merck) (lot # 658211/0884U). On 21-OCT-2007, it was reported that the patient had developed a vulvar crop of vesicles that were round pruritic and mighty painful. It was reported that diagnostics revealed that the varicella titer IgG was positive, and the varicella titer IgM was  negative. Specific sought medical attention and treatment was not reported. A product quality complaint was not reported. Additional information was not available. Additional information has been requested.
sx of paraesthesias of lower extremities began 1wk post vax;sx porgressed to include up to umbilical area & hands;had  weakness of legs;tx w/immunoglobulins;
This spontaneous report as received from a nurse refers to a 6 year old patient of unknown gender. The patient concurrent conditions and medical history was not reported. On 02-MAR-2015 the patient was vaccinated with expired dose of RECOMBIVAX HB (lot # H018689 and expiry date: 07-NOV-2014) 0.5 ml intramuscularly in the right thigh. No adverse effects reported. Additional information is not expected as the reporter did not wish to contact.
pt presented to MD w/ T102 2 days post vax;mom reports T105.9 2 days post vax 14NOV97;also reported high cry that could be relieved;MD dx poss rxn to immun;pt completed 2k course of ATB for cold sx;